Subscribe
shutterstock_1712506348_martinsarts
MartinsArts / Shutterstock.com
8 December 2022AmericasStaff Writer

US supports delay to COVID waiver extension

Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about controversial patent waiver.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?
23 June 2022   The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

article
WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?
23 June 2022   The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.

More on this story

article
WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?
23 June 2022   The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.
Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages